Carl W White

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Science signaling

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

British journal of pharmacology

Pharmacology research & perspectives

University of Nottingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham

United Kingdom

CJ Martin NHMRC Early Career Fellow :: Cell Signaling

University of Western Australia

Australia

Research Fellow :: Harry Perkins Institute of Medical Research

Monash institute of Pharmaceutical Science

Australia

Research Fellow

Monash Institute of Pharmaceutical Sciences

Australia

PhD candidate

Publications

Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Joëlle Goulding, Sarah J Mistry, Mark Soave, Jeanette Woolard, Stephen J Briddon, Carl W White, Barrie Kellam, Stephen J Hill
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels. Pharmacology research & perspectives 9 (3) (2022)
Joëlle Goulding, Alexander Kondrashov, Sarah J Mistry, Tony Melarangi, Nguyen T N Vo, Duc M Hoang, Carl W White, Chris Denning, Stephen J Briddon, Stephen J Hill
The use of fluorescence correlation spectroscopy to monitor cell surface β2-adrenoceptors at low expression levels in human embryonic stem cell-derived cardiomyocytes and fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (4) (2021)
Carl W White, Edilson Dantas da Silva Junior, Linzi Lim, Sabatino Ventura
What makes the α1A -adrenoceptor gene product assume an α1L -adrenoceptor phenotype? British journal of pharmacology 176 (14) (2019)

Carl W White.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carl W White